Physiological Role of the Spleen
The spleen is a specialized lymphoreticular organ that serves as a core component of the human immune system. Its normal physiology encompasses a complex set of vital tasks.
First, it ensures the development of adequate cellular and humoral responses to antigen exposure. Second, the organ acts as a powerful biological filter: it is responsible for eliminating microorganisms and specific antigens from the systemic circulation, as well as recognizing and subsequently removing aging or pathologically altered blood cells. In addition, the spleen actively participates in the regulation of portal blood flow and is capable of assuming the function of extramedullary hematopoiesis (blood formation outside the bone marrow).
Splenomegaly: Causes and Focal Changes
Splenomegaly (splenomegalia) is the pathologic enlargement of the spleen. This condition is rarely an independent disease; most often, it acts as an indicator of other serious underlying pathologic processes in the body.
The etiology of splenomegaly is extremely diverse and includes the following categories:
- Infectious conditions: viral, bacterial, and protozoan infections.
- Immunopathologic processes: including systemic amyloidosis.
- Local and systemic circulatory disturbances: primarily venous congestion.
- Hematologic disorders and malignant neoplasms.
- Lysosomal storage diseases.
Macroscopic and microscopic examination of the enlarged tissue may reveal specific focal lesions. These are most characteristic of conditions such as sepsis, tuberculosis, and syphilis. Focal findings are also observed in the formation of cystic changes, organ infarctions, hematomas, and malignant metastases.
Hypersplenism: Pathogenesis and Classification
Hypersplenism is a severe clinical syndrome in which splenomegaly is accompanied by a pathologic enhancement of organ function.
The pathogenesis of this condition relies on two interrelated mechanisms. On one hand, there is massive destruction or excessive sequestration of formed blood elements directly within the splenic tissue. On the other hand, secondary suppression of bone marrow hematopoiesis is observed. The clinical and laboratory manifestations of hypersplenism include prominent bleeding tendencies and characteristic blood test findings: anemia, leukopenia, and thrombocytopenia.
Clinical practice distinguishes two forms of the syndrome:
- Primary hypersplenism. Associated with prolonged "work hypertrophy" of the organ. It is often congenital and accompanies pathologies such as hereditary spherocytosis (congenital hemolytic anemia), thalassemia, and various hemoglobinopathies.
- Secondary hypersplenism. Develops as a complication of other diseases:
- Infections: malaria, typhoid fever, tuberculosis.
- Systemic diseases: Boeck sarcoidosis, amyloidosis.
- Liver and vascular pathology: liver cirrhosis, portal vein or splenic vein thrombosis.
- Neoplasms and storage diseases: Hodgkin lymphoma, Gaucher disease.
The clinical significance of hypersplenism is that it directly reflects impaired blood-destroying function, leading to a substantial worsening of patients' general condition. In most cases, conservative therapy proves ineffective, and patients require surgical intervention—splenectomy (removal of the organ).
Hyposplenism
Hyposplenism is a condition characterized by depressed splenic function or its complete absence.
Causes of hyposplenism include congenital organ agenesis, targeted surgical removal (splenectomy), or pathologic microvascular occlusion leading to the death of functional tissue.
Peripheral blood findings in hyposplenism are directly opposite to those in hypersplenism. Patients exhibit erythrocytosis, very frequently combined with leukocytosis and thrombocytosis. The main consequences of this condition stem from the loss of the organ's biological filtration role. This leads to a sharp decline in nonspecific resistance and a profound disruption of immune status, rendering the patient highly vulnerable to infectious agents.